RIMR AMD Consortium

What an incredible journey at EURETINA! 🌟 We had a blast showcasing our groundbreaking advanced segmentation algorithm (13 layers, fluids and biomarkers segmented and measured) and demonstrating the power of RetinAI Discovery® to empower clinicians, researchers and pharma companies worldwide! More, we were thrilled to: 1️⃣ Be lead authors and co-authors on 2 poster presentations 2️⃣ Seeing the value of our RetinAI Discovery platform, being presented in 10 additional abstracts & free papers. Check our website if you missed them 👉 https://lnkd.in/eUQXCAQm 3️⃣ Welcoming 20+ KOLs during our Breakfast Session presented by Dr. Aude Ambresin, sharing how RetinAI Discovery has enhanced her Clinical and Research Workflows Additionally, we are very grateful to be a part of the RIMR AMD Consortium where our AI models are being used to evaluate biomarkers within AMD cohorts around the globe. These results were first presented at European Society of Retina Specialists (EURETINA) by Dr. SriniVas Sadda during the InTRIS session. Thank you for the engaging conversations, insights, and discussions around the transformative impact of AI in Ophthalmology 🤝👁️ Missed us at EURETINA? Don’t worry! We’re excited to announce we'll be at AAO in 2 weeks! Come meet us at our booth #4256 and see how our platform RetinAI Discovery® can revolutionize your data management and automated analysis (AI) workflows. Book time with us in advance here 👉 https://lnkd.in/eAYnniYj #RetinAI #EURETINA #OphthalmologyInnovation #AIinHealthcare #AAO2024 #SeeYouSoon

Exciting Partnership Announcement: Retinai joins Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium! RetinAI is proud to announce its collaboration with RIMR AMD Consortium, a non-profit group of physicians, researchers, and industry partners dedicated to advancing research in Age-related Macular Degeneration (AMD). #AMD is a pressing global health concern affecting 170 million individuals and ranks as the third leading cause of #vision loss worldwide. RIMR members across the globe can now seamlessly connect through our cloud-based platform, Discovery®, fostering frictionless collaboration and new insights on global AMD datasets. Carlos Ciller, our CEO and Co-Founder, states: "By being a member of RIMR, we are setting the foundation to connect leading AMD experts from around the world to help advance their important biomarker-led research." SriniVas Sadda, Executive Committee Chair for RIMR, Director of the AI Laboratory at Doheny Eye Institute says: “RetinAI’s focus on digital health technologies and connectivity in Ophthalmology will enable us to build a highly-diverse database in AMD, providing the enriched insights to advance our understanding of AMD to drive our goal for finding a cure in AMD.” Working together to improve patient care and provide a better healthcare of tomorrow! Read more: https://lnkd.in/eWGMaguk #AMD #research #AMDResearch #biomarker #ophthalmology #retina #eyecare #healthcare #digitalhealth #artificialintelligence #AI #machinelearning